Evaluation of Antidiabetic Drug Utilization Patterns in Type 2 Diabetes Mellitus Patients
International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (06)
DOI: 10.25258/ijpqa.16.6.76 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Mehre Darakhshan Mehdi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 Diabetes Mellitus (T2DM) is a major public health concern requiring long-term pharmacological management. Drug utilization studies help evaluate prescribing trends and rational use of antidiabetic medications.
Aim
To evaluate antidiabetic drug utilization patterns among patients with Type 2 Diabetes Mellitus attending a tertiary care teaching hospital. Methodology: A prospective observational study was conducted in the Department of Pharmacology, ESIC Medical College and Hospital, Bihta, Patna, Bihar, over one year from January 2023 to December 2023. Eighty adult T2DM patients receiving antidiabetic therapy were enrolled. Demographic, clinical, and prescriptionrelated data were collected and analyzed using descriptive statistics.
Results
Most patients belonged to the 46–60 years age group (37.5%) and were male (57.5%). The majority had diabetes for 1–5 years (40%). Dual therapy was the most commonly prescribed regimen (45%), followed by monotherapy (30%). Metformin was the most frequently prescribed antidiabetic drug (85%), followed by sulfonylureas (47.5%). DPP-4 inhibitors and SGLT-2 inhibitors were prescribed in 30% and 25% of patients, respectively. Generic prescribing was observed in 65% of prescriptions, while 80% of drugs were prescribed from the National List of Essential Medicines.
Conclusion
Metformin-based combination therapy predominated in T2DM management. Prescribing practices demonstrated substantial adherence to rational and evidence-based treatment principles
Zitieren
APA
Mehdi, M. D. (2026). Evaluation of Antidiabetic Drug Utilization Patterns in Type 2 Diabetes Mellitus Patients. International Journal of Pharmaceutical Quality Assurance, 16(06). https://doi.org/10.25258/ijpqa.16.6.76
Vancouver
Mehdi MD. Evaluation of Antidiabetic Drug Utilization Patterns in Type 2 Diabetes Mellitus Patients. International Journal of Pharmaceutical Quality Assurance. 2026;16(06). doi:10.25258/ijpqa.16.6.76
BibTeX
@article{Mehdi2026,
author = {Mehdi, Mehre Darakhshan},
title = {Evaluation of Antidiabetic Drug Utilization Patterns in Type 2 Diabetes Mellitus Patients},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {06},
doi = {10.25258/ijpqa.16.6.76}
}
EUVIMED